What is Apogee Bio-Pharm?
Apogee Bio-Pharm operates as a specialized pharmacy provider that transcends traditional dispensing models by emphasizing clinical outcomes and patient-centric care. By leveraging over 25 years of expertise in medication therapy management and compliance monitoring, the company functions as a critical partner for both patients and healthcare providers. Their service architecture is designed to bridge the gap between prescription fulfillment and long-term health management, offering robust support for chronic illness through education and proactive clinical intervention. This integrated approach allows prescribers to extend their care settings, ensuring that complex treatment plans are managed with precision and empathy.
How much funding has Apogee Bio-Pharm raised?
Apogee Bio-Pharm has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Apogee Bio-Pharm
PPP
Public-Private Partnership
What's next for Apogee Bio-Pharm?
With the influx of capital from this late-stage funding, Apogee Bio-Pharm is poised to accelerate its market expansion and enhance its digital health infrastructure. The strategic focus will likely shift toward scaling its clinical team and broadening the reach of its medication therapy management programs. By deepening its collaboration with healthcare providers, the company aims to solidify its position as a leader in specialty pharmacy services, ultimately driving better patient outcomes and operational efficiencies within the broader healthcare ecosystem. Future growth will be defined by the firm's ability to maintain its high-touch, family-oriented care model while navigating the complexities of large-scale pharmaceutical distribution.
See full Apogee Bio-Pharm company page
